TELA Bio (TELA)
(Delayed Data from NSDQ)
$1.92 USD
+0.07 (3.78%)
Updated Aug 5, 2025 09:48 AM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TELA 1.92 +0.07(3.78%)
Will TELA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TELA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TELA
NeoGenomics (NEO) Meets Q2 Earnings Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
TELA: What are Zacks experts saying now?
Zacks Private Portfolio Services
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates
Other News for TELA
TELA Bio to Announce Second Quarter 2025 Financial Results | TELA Stock News
TELA Bio (TELA) Receives a Buy from Lake Street
12 Health Care Stocks Moving In Monday's After-Market Session
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News
NORTH RUN CAPITAL, LP Acquires Significant Stake in TELA Bio Inc